期刊
JOURNAL OF NEUROIMMUNOLOGY
卷 258, 期 1-2, 页码 71-76出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2013.02.015
关键词
Multiple sclerosis; ALCAM; HLA-DRB1*1501; ALCAM-HLA-DRB1*1501 interaction
Activated leukocyte cell adhesion molecule (ALCAM) is a molecule involved in leukocyte migration across the blood-brain barrier which is a key stage in multiple sclerosis (MS) pathogenesis. The present study is the first to report evidence of the association of rs6437585 ALCAM polymorphism with risk and progression of MS. Our investigation revealed that rs6437585CT individuals had higher risk of MS (OR =, 234; 95%CI = 1.22-4.51; P = 0.011) and over 2 years earlier age of onset (95%CI = 0.16-4.41, P = 0.036). Moreover, we demonstrated that two ALCAM polymorphisms, rs11559013 and rs34926152, although not associated with MS itself, modify HLA-DRB1*1501 effect Results obtained from logistic regression analysis showed five-fold lower risk for MS for both rs11559013GA/HLA-DRB1*1501+ and rs34926152GT/HLA-DRB1*1501+ individuals. This observations may suggest protective role against MS for both rs11559013GA and rs34926152GT genotypes in HLA-DRB1*1501 positive individuals. (C) 2013 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据